In fact, already some decades ago it was shown that glucagon levels increase at low glycemic levels with consequent stimulation of glycogenolysis and gluconeogenesis by the liver, indicating that such glucagon-based counter-regulation mechanisms are crucial for preventing hypoglycemia [2,3,4]. The gene discussed is GCG; the disease is Hypoglycemia.